Maven's Asset-Light Margin Advantage

Maven looks more like software with a clinician marketplace attached than a healthcare operator, and that changes the margin structure. Most revenue now comes from employer and health plan contracts, while care is delivered through a network of 1,000 plus independent providers paid per consult, so Maven avoids owning clinics, carrying large provider payroll, or passing through most IVF procedure costs that weigh on Kindbody and Progyny gross margins.1 2 3 4 5

• Maven can add a new employer in another country by turning on local provider supply in its network, not by leasing space, buying lab equipment, or staffing a clinic. That is how it scaled to 175 countries and 17.5M covered lives while staying centered on a platform fee plus per member model.1 2 5
• Kindbody is built very differently. It sells employer benefits, but also operates its own signature clinics and in clinic services, which means more control over care delivery and more revenue per patient, but also more fixed cost, more operational complexity, and more capital tied up in physical sites.3 6
• Progyny shows the other low margin path. Its 2024 revenue was $1.17B with 21.7% gross margin, because cost of services includes the medical treatment and pharmacy claims paid for fertility care. Maven sits further upstream as the benefits and navigation layer, so less of each dollar flows straight back out to treatment providers.4 7

The next step is Maven pushing this model across more life stages, from fertility into pregnancy, pediatrics, and menopause, so the same light infrastructure supports more covered members and more wallet share. If that continues, Maven can keep compounding like a global benefits platform rather than a clinic rollup.1 2